COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
EURAZEO SIGNE UN ACCORD POUR LA VENTE DE 100% DU CAPITAL DE PETERS SURGICAL A ADVANCED MEDICAL SOLUTIONS GROUP PLC
Eurazeo signe un accord pour la vente de 100% du capital de Peters Surgical à Advanced Medical Solutions Group plc, renforçant ainsi sa présence mondiale dans le secteur des dispositifs de cicatrisation -
COMMUNIQUÉ RÉGLEMENTÉ
EURAZEO SIGNS AN AGREEMENT TO SELL 100% OF PETERS SURGICAL’ SHARE CAPITAL TO ADVANCED MEDICAL SOLUTIONS GROUP PLC
Eurazeo signs agreement to sell Peters Surgical's share capital to Advanced Medical Solutions Group PLC. Transaction to enhance surgical product portfolio and global presence -
COMMUNIQUÉ DE PRESSE
Bioz and Teledyne LABS Announce AI-Powered Partnership Enabling Easy Access to Product Citations From Scientific Publications
Bioz, Inc. partners with Teledyne LABS to provide complete laboratory instrument solutions, enhancing visibility and aiding customers in finding solutions. Teledyne's website now displays Bioz Prime Badges for product citation data -
COMMUNIQUÉ RÉGLEMENTÉ
Point d’étape sur le processus de restructuration : Solocal soutient l’offre d’Ycor et consultera ses créanciers
Solocal soutient l'offre d'Ycor pour sa restructuration financière avec consultation des créanciers. Dirigeants et conseils unanimes. Prochaines étapes et données financières estimées dévoilées -
COMMUNIQUÉ RÉGLEMENTÉ
Update on the restructuring process: Solocal supports Ycor’s offer and will consult its financial creditors
Solocal Group updates on the restructuring process, supporting Ycor's offer for debt reduction and cash injection, consulting financial creditors. CEO emphasizes sustainability and employee protection -
-
COMMUNIQUÉ DE PRESSE
AUSTRIAN POST 2023 Results: Increase in 2023 revenue and earnings driven by strong parcel growth and improvement in bank99
Austrian Post reports 2023 revenue increase driven by strong parcel growth & bank99 improvements. Earnings up: EBITDA +5.0%, EBIT +1.0%, EPS +5.5%. Dividend proposal EUR 1.78 per share -
-
COMMUNIQUÉ DE PRESSE
Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023
Medacta Group SA reports robust revenue growth of 19.5% in FY 2023, with adjusted EBITDA margin at 26.3% (27.9% at constant currency). CEO discusses positive momentum and market strategies for 2024
